1-3 of 3
Salem Abi Nehme
Close
Sort by
Journal Articles

Patient Preferences for Maintenance Treatment of Acute Myeloid Leukemia: Results of a Discrete Choice Experiment

Tommi Tervonen, Katelyn Cutts, Jaein Seo, Salem Abi Nehme, Ignazia La Torre, Thibaud Prawitz, Clara Chen, CL Beach, Jenny Wang
Journal: Blood
Blood (2020) 136 (Supplement 1): 38–39.
https://doi.org/10.1182/blood-2020-136335
Published: 2020
Journal Articles

Improved Overall Survival with Enasidenib Compared with Standard of Care Among Patients with Relapsed or Refractory Acute Myeloid Leukemia and IDH2 Mutations: A Propensity Score Matching Analysis Using Data from the AG221-C-001 Trial and Two Data Sources from France and Germany

Stephane De Botton, Joseph M Brandwein, MD, Eytan M. Stein, MD, Andrew H. Wei, Daniela Weber, Arnaud Pigneux, Nicolas Boissel, MD PhD, Peter Paschka, MD, Konstanze Döhner, Salem Abi Nehme, Mark G. Frattini, MD, Roland Marion-Gallois, Jixian (Jason) Wang, Chris Cameron, Muhaimen Siddiqui, Rana A. Qadeer, Hartmut Döhner
Journal: Blood
Blood (2019) 134 (Supplement_1): 3893.
https://doi.org/10.1182/blood-2019-122700
Published: 2019
Journal Articles

The Real-World Incidence of Relapse in Acute Myeloid Leukemia (AML): A Systematic Literature Review (SLR)

Esther N. Oliva, Jacob Franek, Dipen Patel, Omer Zaidi, Salem Abi Nehme, Antonio M. Almeida
Journal: Blood
Blood (2018) 132 (Supplement 1): 5188.
https://doi.org/10.1182/blood-2018-99-111839
Published: 2018